摘要
目的探讨血清β2-微球蛋白(β2-MG)在肿瘤诊断和监测中的临床意义。方法采用β2-MG(免疫比浊法)试剂对123例肿瘤患者(观察组)和95例健康体检者(对照组)的血清β2-MG水平进行检测,并比较分析。结果观察组血清β2-MG含量明显高于对照组,且差异有统计学意义(P<0.05);且随着恶性肿瘤的不断恶化,其血清β2-MG水平也相应升高。结论血清β2-MG水平可以作为肿瘤患者的一项临床指标,在肿瘤的诊断和监测中有重要的意义。
Objective To study the clinical significance of serum β2-microglobulin(β2-MG) in the diagnosis and monitor of tumor. Methods The β2-MG reagent(immunoturbidimetry method)was used to assay the serum β2-MG level in 123 tumor patients(observation group) and 95 healthy people(control group). The detection results were per- formed the comparative analysis. Results The serum β2-MG level in the observation group was obviously higher than that in the control group, the difference was statistically significant (P〈0. 05). With the worsening of malignant tumor,the serum β2-MG level was also correspondingly risen. Conclusion The serum β2-MG level can be used as a clinical index of tumor patient and has the important significance in diagnosis and monitoring of tumor.
出处
《检验医学与临床》
CAS
2013年第6期699-699,701,共2页
Laboratory Medicine and Clinic